Annual Total Liabilities
$6.13 M
+$1.21 M+24.65%
31 December 2023
Summary:
CNS Pharmaceuticals annual total liabilities is currently $6.13 million, with the most recent change of +$1.21 million (+24.65%) on 31 December 2023. During the last 3 years, it has risen by +$4.23 million (+221.87%). CNSP annual total liabilities is now at all-time high.CNSP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$4.06 M
-$2.71 M-40.01%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly total liabilities is currently $4.06 million, with the most recent change of -$2.71 million (-40.01%) on 30 September 2024. Over the past year, it has dropped by -$11.90 thousand (-0.29%). CNSP quarterly total liabilities is now -40.01% below its all-time high of $6.76 million, reached on 30 June 2024.CNSP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.6% | -0.3% |
| 3 y3 years | +221.9% | +68.5% |
| 5 y5 years | +397.6% | +190.3% |
CNSP Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +221.9% | -40.0% | +339.1% |
| 5 y | 5 years | at high | +1872.0% | -40.0% | +1453.2% |
| alltime | all time | at high | +2678.9% | -40.0% | +1453.2% |
CNS Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.06 M(-40.0%) |
| June 2024 | - | $6.76 M(+11.0%) |
| Mar 2024 | - | $6.09 M(-0.7%) |
| Dec 2023 | $6.13 M(+24.6%) | $6.13 M(+50.7%) |
| Sept 2023 | - | $4.07 M(+1.8%) |
| June 2023 | - | $4.00 M(+1.9%) |
| Mar 2023 | - | $3.92 M(-20.3%) |
| Dec 2022 | $4.92 M(+89.7%) | $4.92 M(+295.4%) |
| Sept 2022 | - | $1.24 M(+34.7%) |
| June 2022 | - | $923.90 K(-13.6%) |
| Mar 2022 | - | $1.07 M(-58.8%) |
| Dec 2021 | $2.59 M | $2.59 M(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $2.41 M(+31.5%) |
| June 2021 | - | $1.83 M(-3.7%) |
| Mar 2021 | - | $1.90 M(-0.2%) |
| Dec 2020 | $1.91 M(+512.7%) | $1.91 M(+273.0%) |
| Sept 2020 | - | $510.80 K(+95.6%) |
| June 2020 | - | $261.20 K(-22.3%) |
| Mar 2020 | - | $336.00 K(+8.0%) |
| Dec 2019 | $311.00 K(-74.8%) | $311.00 K(-77.7%) |
| Sept 2019 | - | $1.40 M(+10.6%) |
| June 2019 | - | $1.26 M(+2.6%) |
| Dec 2018 | $1.23 M(+458.5%) | $1.23 M |
| Dec 2017 | $220.70 K | - |
FAQ
- What is CNS Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual total liabilities year-on-year change?
- What is CNS Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly total liabilities year-on-year change?
What is CNS Pharmaceuticals annual total liabilities?
The current annual total liabilities of CNSP is $6.13 M
What is the all time high annual total liabilities for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual total liabilities is $6.13 M
What is CNS Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CNSP annual total liabilities has changed by +$1.21 M (+24.65%)
What is CNS Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CNSP is $4.06 M
What is the all time high quarterly total liabilities for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly total liabilities is $6.76 M
What is CNS Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CNSP quarterly total liabilities has changed by -$11.90 K (-0.29%)